Macsart CL 10mg/40mg Tablet is a combination antihypertensive medication containing Cilnidipine 10mg and Telmisartan 40mg. Cilnidipine, a calcium channel blocker, selectively inhibits L-type and N-type calcium channels, leading to vasodilation of peripheral arteries and reduction of sympathetic nerve activity, thereby lowering blood pressure. Telmisartan, an angiotensin II receptor blocker (ARB), antagonizes the AT1 receptor, preventing angiotensin II-mediated vasoconstriction and aldosterone secretion, resulting in decreased vascular resistance and blood pressure. The dual mechanism of action provides effective and sustained control of hypertension, improving cardiovascular outcomes and reducing the risk of stroke, myocardial infarction, and renal complications. Macsart CL is indicated for the management of essential hypertension, particularly in patients requiring combination therapy for optimal blood pressure control. It is generally well tolerated; common adverse effects may include dizziness, headache, and peripheral edema. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated during pregnancy and lactation. Regular monitoring of blood pressure, renal function, and electrolyte levels is recommended during therapy. Macsart CL 10mg/40mg Tablet offers a convenient and efficacious option for patients requiring combined antihypertensive treatment.